Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Current and emerging strategies in the management of Crohn's disease.

Randall C, Vizuete J, Wendorf G, Ayyar B, Constantine G.

Best Pract Res Clin Gastroenterol. 2012 Oct;26(5):601-10. doi: 10.1016/j.bpg.2012.11.006. Review.

PMID:
23384805
2.

Management of Crohn's disease--a practical approach.

Knutson D, Greenberg G, Cronau H.

Am Fam Physician. 2003 Aug 15;68(4):707-14. Review.

3.

Review article: medical treatment of mild to moderately active Crohn's disease.

Löfberg R.

Aliment Pharmacol Ther. 2003 Jun;17 Suppl 2:18-22. Review.

4.

Maintenance of remission in Crohn's disease: current and emerging therapeutic options.

Brookes MJ, Green JR.

Drugs. 2004;64(10):1069-89. Review.

PMID:
15139787
5.

Review article: medical, surgical and radiological management of perianal Crohn's fistulas.

Tozer PJ, Burling D, Gupta A, Phillips RK, Hart AL.

Aliment Pharmacol Ther. 2011 Jan;33(1):5-22. doi: 10.1111/j.1365-2036.2010.04486.x. Epub 2010 Oct 29. Review.

6.

Management of perianal Crohn's disease.

Wise PE, Schwartz DA.

Clin Gastroenterol Hepatol. 2006 Apr;4(4):426-30. Review. No abstract available.

PMID:
16616345
7.

Intercenter variation in initial management of children with Crohn's disease.

Kappelman MD, Bousvaros A, Hyams J, Markowitz J, Pfefferkorn M, Kugathasan S, Rosh J, Otley A, Mack D, Griffiths A, Evans J, Grand R, Langton C, Kleinman K, Finkelstein JA.

Inflamm Bowel Dis. 2007 Jul;13(7):890-5.

PMID:
17286275
8.

[Treatment of colitis ulcerosa and Crohn's disease].

Kovács A.

Orv Hetil. 2006 Apr 23;147(16):755-8. Review. Hungarian. No abstract available.

PMID:
16711262
9.

[Biological compounds in the treatment of Crohn's disease].

Dinari G.

Harefuah. 2001 Apr;140(4):316-8. Hebrew. No abstract available.

PMID:
11303396
10.

Practical application of anti-TNF therapy for luminal Crohn's disease.

Kamm MA, Ng SC, De Cruz P, Allen P, Hanauer SB.

Inflamm Bowel Dis. 2011 Nov;17(11):2366-91. doi: 10.1002/ibd.21655. Epub 2011 Feb 18. Review.

PMID:
21337669
11.

Update on the management of Crohn's disease.

Buchner AM, Blonski W, Lichtenstein GR.

Curr Gastroenterol Rep. 2011 Oct;13(5):465-74. doi: 10.1007/s11894-011-0220-x. Review.

PMID:
21792543
12.

Treatment-resistant lingual Crohn's disease disappears after infliximab.

Brunner B, Hirschi C, Weimann R, Seibold F.

Scand J Gastroenterol. 2005 Oct;40(10):1255-9.

PMID:
16265783
13.

Infliximab: lifetime use for maintenance is appropriate in Crohn's Disease. PRO: maintenance therapy is superior to episodic therapy.

Lichtenstein GR.

Am J Gastroenterol. 2005 Jul;100(7):1433-5. Review. No abstract available.

PMID:
15984959
14.

Infliximab in Crohn's disease: early and long-term treatment.

Armuzzi A, De Pascalis B, Fedeli P, De Vincentis F, Gasbarrini A.

Dig Liver Dis. 2008 Jul;40 Suppl 2:S271-9. doi: 10.1016/S1590-8658(08)60537-X.

PMID:
18599000
15.

Steroid-independent Crohn's disease patients also benefit from combination therapy of infliximab plus azathioprine.

van den Brande JM, Peppelenbosch MP, Hommes DW.

Gastroenterology. 2006 Oct;131(4):1362-3. No abstract available. Erratum in: Gastroenterology. 2007 Jan;132(1):466. Hommes, Daan W [added].

PMID:
17030216
16.

Introduction: anti-TNF strategies in the treatment of Crohn's disease.

Rutgeerts PJ, Targan SR.

Aliment Pharmacol Ther. 1999 Sep;13 Suppl 4:1. No abstract available.

17.

Review article: infliximab for Crohn's disease treatment--shifting therapeutic strategies after 10 years of clinical experience.

Danese S, Colombel JF, Reinisch W, Rutgeerts PJ.

Aliment Pharmacol Ther. 2011 Apr;33(8):857-69. doi: 10.1111/j.1365-2036.2011.04598.x. Epub 2011 Feb 15. Review.

18.

Biological therapy in the management of recent-onset Crohn's disease: why, when and how?

Löwenberg M, Peppelenbosch M, Hommes D.

Drugs. 2006;66(11):1431-9. Review.

PMID:
16906776
19.

Infliximab vs adalimumab for Crohn's disease.

Dhillon AS, Harris AW.

Clin Gastroenterol Hepatol. 2015 Jan;13(1):210. doi: 10.1016/j.cgh.2014.06.012. Epub 2014 Jun 19. No abstract available.

PMID:
24954114
20.

Novel therapies for Crohn's disease: focus on immunomodulators and antibiotics.

Wilhelm SM, Taylor JD, Osiecki LL, Kale-Pradhan PB.

Ann Pharmacother. 2006 Oct;40(10):1804-13. Epub 2006 Sep 19. Review.

PMID:
16985094

Supplemental Content

Support Center